Income Taxes (Tables)
|
12 Months Ended |
Jun. 30, 2025 |
Income Tax Disclosure [Abstract] |
|
Schedule of income tax expense (benefit) |
Income tax expense (benefit) for the years ended June 30, 2023, 2024 and 2025 consists of the following: | | | | | | | | | | | | | | | | | | | Year Ended June 30, | | 2023 | | 2024 | | 2025 | Current taxes | | | | | | Federal | $ | 1,702 | | | $ | 30,900 | | | $ | 65,188 | | State and local | 2,625 | | | 11,524 | | | 18,918 | | International | $ | — | | | $ | — | | | 999 | | Deferred taxes: | | | | | | Federal | 17,973 | | | 26,438 | | | (4,072) | | State and local | (4,508) | | | 1,387 | | | 940 | | International | $ | — | | | $ | — | | | $ | (37) | | Total income tax expense (benefit) | $ | 17,792 | | | $ | 70,249 | | | $ | 81,936 | |
|
Schedule of tax rate reconciliation by applying the U.S. federal income tax rate to pretax income |
Income tax expense (benefit) differed from the amounts computed by applying the U.S. federal income tax rate of 21% for the years ended June 30, 2023, 2024 and 2025 to pretax income as a result of the following: | | | | | | | | | | | | | | | | | | | Year Ended June 30, | | 2023 | | 2024 | | 2025 | Income tax expense (benefit) at statutory federal rate | 21.0 | % | | 21.0 | % | | 21.0 | % | Increase (reduction) in income taxes resulting from: | | | | | | Research and development credit and other credits | (3.1) | | | (2.9) | | | (2.0) | | Non-deductible expenses | 1.0 | | | 0.7 | | | 0.5 | | Change in valuation allowance | (2.8) | | | (0.5) | | | — | | Stock-based compensation expense | (6.1) | | | 2.7 | | | 1.8 | | State and local income taxes, net of federal income tax benefit | 1.3 | | | 4.3 | | | 5.1 | | | | | | | | Other | (0.1) | | | 0.1 | | | 0.1 | | | 11.2 | % | | 25.4 | % | | 26.5 | % |
|
Schedule of tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities |
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities at June 30, 2024 and 2025 are presented below. | | | | | | | | | | | | | June 30, | | 2024 | | 2025 | Deferred tax assets: | | | | Operating lease liabilities | $ | 14,141 | | $ | 14,457 | Accrued expenses | 19,706 | | 23,101 | Stock-based compensation | 28,595 | | 25,970 | Net operating loss carryforwards | 4,282 | | 20,471 | Federal and state tax credits | 17,907 | | 16,196 | Research and development costs | 29,718 | | 60,611 | | | | | Total deferred tax assets | 114,349 | | 160,806 | Valuation allowance | — | | | (232) | | Net deferred tax assets | 114,349 | | 160,574 | Deferred tax liabilities: | | | | Deferred contract costs | (116,004) | | | (134,448) | | Operating lease right-of-use assets | (8,775) | | (9,400) | Intangible assets | (2,661) | | (20,269) | Depreciation | (10,559) | | | (8,976) | | Other | (358) | | | (2,286) | | Total deferred tax liabilities | (138,357) | | | (175,379) | | Net deferred tax liabilities | $ | (24,008) | | | $ | (14,805) | |
|
Schedule of unrecognized tax benefits |
As of June 30, 2024 and 2025, the Company’s liabilities for unrecognized tax benefits, which would impact the Company’s effective tax rate if recognized, are presented below. The Company will include applicable penalties and interest when the benefit is recognized: | | | | | | | | | | | | | Year Ended June 30, | | 2024 | | 2025 | Unrecognized tax benefits at beginning of the year | $ | 1,552 | | | $ | 2,435 | | Additions for current year tax positions | 769 | | | 848 | | Additions for tax positions of prior periods | 114 | | | 23 | | | | | | Unrecognized tax benefit at end of year | $ | 2,435 | | | $ | 3,306 | |
|